Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Clinical trial NCT04740827 · COMPLETED

Trial details

NCT number: NCT04740827
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Episodic Migraine

Start date: 2021-03-05
Primary completion: 2022-08-04
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.